CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 10 enrolled
Drug / intervention
Almond Butterother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03826472
NCT03826472Phase 2Completed
CompareCT.gov

Almond Butter and Fasting Glucose in Adults With Type 2 Diabetes

Penn State University·interventional·Posted Feb 1, 2019·Updated Apr 9, 2024

In Brief

A Phase 2 clinical trial evaluating Almond Butter for Type2 Diabetes. Completed, enrolled 10 participants across 1 site.

Detailed Summary

A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType2 Diabetes
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedFeb 1, 2019
Enrollment StartMar 8, 2019
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.4 years ago

Interventions

Almond Butterother

Natural almond butter